Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
  Pharmaceutical Technology Europe E-Alert
 
27 January 2012

IN THIS ISSUE
Outsourcing growth
Personalised medicine
Animal experiments
EMA concept paper

 
Outsourcing revenue to grow by 50%
A new report from Frost & Sullivan has forecast that the utilisation rates of pharmaceutical manufacturing plants will decrease by half in the coming years, triggering an increase in outsourcing. More...
 
MS drug personalised with risk diagnostic
The FDA has approved a safety label change for Biogen and Elan’s multiple sclerosis drug Tysabri (natalizumab) after the company developed a diagnostic test that can help identify patients at risk of developing a serious brain infection, which has been associated with the drug. More...
 
Call for funding to end animal experiments
As the EU debates how best to spend billions of Euros’ worth of research funding, the Humane Society International/Europe has issued a call to develop in vitro and computational techniques that can replace the use of animals in medical experiments. More...
 
EMA releases pharmacogenomics concept paper
The EMA has released a concept paper for a guideline on pharmacogenomic methodologies in the evaluation of authorised medicines to address the fact that genetic differences can cause variability in drug-therapy efficacy and safety. More...
 
Genzyme to manufacture drug in critically short supply
The FDA has approved Genzyme’s US manufacturing facility in Framingham for the production of Fabrazyme (agalsidase beta), which is used to treat a rare genetic disorder for which it is the only FDA-approved treatment. More...
 
Join our community on LinkedIn
Want to discuss any of this week’s news stories or any other hot topics in the industry? Then why not join our group on LinkedIn? More...
Key Topics:

Latest blog posts
Celebrity chef and pharma unite
Generic drug and biosimilar user fees gain traction
A new way to share best practices
More blog posts

Latest columns
European pharma companies set to surge ahead of US rivals
Contract services in 2012
Packaging innovations for 2012
More articles

Upcoming events
Informex (14–17 February | USA)
Pharmapack (15–16 February | France)
Global ManuCHEM Strategies 2012 (13–14 February | Germany)
More events

Products/Service Profiles
Jones Lang LaSalle

Specialist chemicals plant for sale in Church Village, South Wales.  Clariant Chemicals to dispose of Parabens & Polymer production facility, Jones Lang LaSalle’s Cardiff office instructed to market.
Read more

 
Sterilin

Superior quality pipettes for endotoxin testing
Sterilin single-use, serological pipettes are certified non-pyrogenic to a lower level than ever before (0.01EU/ml), making them ideal for pharmaceutical and medical device manufacturers to use when ensuring that their products are free from endotoxin contamination.
Read more

 
Survey
Is lyophilisation technology advancing fast enough to meet demands from manufacturers of increasingly sensitive biopharmaceutical products?
Yes 41%
 
No 59%

This week we would like to know...

What is the most important change that has influenced chemical API manufacturing during the past 10 years?

Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing [email protected] or by mail
at Advanstar Communications Inc., Bridgegate Pavilion, 4A Chester Business Park, Wrexham Road, Chester, CH4 9QH, UK.